Rodzajewska, A., Kuryło, W., & Szklener, K. (2023). Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation. Journal of Education, Health and Sport, 31(1), 138–147. https://doi.org/10.12775/JEHS.2023.31.01.012